Unisphere Establishment’s Pfizer PFE Stock Holding History

Unisphere Establishment’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353M	Hold	14,650,000	–	–	3%	12
2026 Q1	$411M	Hold	14,650,000	–	–	3.46%	10
2025 Q4	$365M	Buy	14,650,000 +250,000	+2%	+$6.3M	2.73%	10
2025 Q3	$367M	Buy	14,400,000 +1,750,000	+14%	+$43.2M	2.88%	10
2025 Q2	$307M	Hold	12,650,000	–	–	2.47%	11
2025 Q1	$321M	Hold	12,650,000	–	–	2.8%	10
2024 Q4	$336M	Hold	12,650,000	–	–	2.93%	11
2024 Q3	$366M	Hold	12,650,000	–	–	3.47%	10
2024 Q2	$354M	Hold	12,650,000	–	–	3.56%	10
2024 Q1	$351M	Buy	12,650,000 +1,125,000	+10%	+$31.2M	3.55%	11
2023 Q4	$332M	Buy	+11,525,000	New	+$348M	3.43%	10

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Unisphere Establishment's PFE Position: Q2 2026 in Review

Unisphere Establishment held its Pfizer (PFE) position steady in Q2 2026 at 14,650,000 shares worth $353M. The position accounts for 3% of the portfolio, ranked #12.

Unisphere Establishment first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $411M in Q1 2026. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Unisphere Establishment held 14,650,000 shares of Pfizer worth $353M as of Q2 2026.
Unisphere Establishment left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 3% of Unisphere Establishment's portfolio in Q2 2026, its #12 holding.
Unisphere Establishment first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Unisphere Establishment's Pfizer position peaked at $411M in Q1 2026.
2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Unisphere Establishment's 13F filing for Q2 2026, filed 14 Aug 2026.